In today's episode we're going to talk first about the ongoing COPD triplet wars - with the most recent approval of Breztri for maintenance treatment of patients with chronic obstructive pulmonary disease. We'll also talk about the approval Xywav to treat cataplexy, Xeglyze for head lice, and we’ll also bring up approval of Tecartus, a new CAR-T therapy. Don't forget to like, share, and subscribe! Enjoy!